NCT03484234

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)

A Multi-center, Randomized, Study to Compare the Effectiveness of Sirolimus-eluting Stent (Ultimaster Stent) or Everolimus-eluting Stent (XIience Alpine Stent) for Long Coronary Lesions.

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Seung-Jung Park · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This study compares angiographic and clinical outcomes in patients with long coronary lesions treated with sirolimus-eluting stent (Ultimaster stent) or everolimus-eluting stent (Xience Alpine stent). The study uses a randomized, multicenter, controlled design approach.

Conditions

• Coronary Artery Disease
• Coronary Stenosis

Interventions

Type	Name	Description
DEVICE	Ultimaster stent	Percutaneous coronary intervention with Ultimaster stent for long lesion
DEVICE	Xience alpine stent	Percutaneous coronary intervention with Xience alpine stent for long lesion

Timeline

• Start date: 2018-07-27
• Primary completion: 2019-09-06
• Completion: 2019-09-06
• First posted: 2018-03-30
• Last updated: 2019-09-10

Locations

2 sites across 1 country: South Korea